NewsHK
Medical device companies carry the FDA's 510(k) clearance calendar as a commercial signal, with submission timing telling the market how far a product sits from a potential launch window.
PAVmed is targeting an early 2027 filing for its Veris device and is simultaneously advancing a 510(k) regulatory pathway for its PortIO product.
Running two tracks concurrently concentrates PAVmed's submission preparation.
Each 510(k) filing requires an independent data package, and the company has confirmed the PortIO pathway is active without giving a target submission date for that product.
Keep reading